Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

NCT03270059 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Neoplasm
Cranial Nerve Disorder
Metastatic Malignant Neoplasm in the Brain

Interventions

DRUG: Ferumoxytol
DRUG: Gadolinium
PROCEDURE: Magnetic Resonance Imaging

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]